ALKBH8 and urinary bladder carcinoma: Silencing of ALKBH8 also significantly inhibited the invasion, angiogenesis, and growth of bladder cancer cells by downregulating the protein expression of survivin, an anti-apoptotic factor, which is upregulated in bladder cancer (187).